Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 21 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

27%

3 of 11 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (10)
P 1 (2)
P 2 (3)
P 3 (2)
P 4 (1)

Trial Status

Completed11
Recruiting4
Not Yet Recruiting2
Active Not Recruiting2
Withdrawn1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT05384561Not ApplicableRecruitingPrimary

Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19

NCT07706829Not Yet Recruiting

Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study

NCT06600438Not ApplicableRecruitingPrimary

Slow-SPEED UK: A Double-Blind Randomised Feasibility Trial

NCT06733636Not ApplicableRecruiting

Scents of Progress: Leveraging a Novel Device for Olfactory Training in Older Adults

NCT06019000Phase 2CompletedPrimary

Study of CYR-064 Versus Placebo in Patients.

NCT05445921Phase 1Completed

Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction

NCT04661800Not ApplicableCompleted

Study of Olfactory Disorders in Patients With Cardiac Amyloidosis

NCT06142565Not ApplicableCompletedPrimary

Treatment of Postviral Olfactory Dysfunction

NCT07151703Phase 3Not Yet Recruiting

Topical Versus Injection PRP for Olfactory Dysfunction

NCT06817499Not ApplicableActive Not RecruitingPrimary

Treatment of Olfactory Dysfunction Using Vagus Nerve Stimulation

NCT07122037Not ApplicableActive Not Recruiting

Mechanical and Sensorial Training in the Olfactive Rehabilitation of Patients With Total Laryngectomy

NCT05364125Not ApplicableRecruiting

Olfactory Training on Smell Dysfunction Patients in HK

NCT05421221Not ApplicableCompleted

Olfactory Training in COVID-19 Associated Loss of Smell

NCT06498687Phase 1WithdrawnPrimary

Theophylline Nasal Spray for PD-Related Hyposmia and Anosmia

NCT05184192Phase 2Completed

Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction

NCT05837637UnknownPrimary

The Vietnamese Smell Identification Test in the Diagnosis of Parkinson's Disease

NCT04789499Phase 2Completed

Smell in Covid-19 and Efficacy of Nasal Theophylline

NCT04853836Phase 4Completed

Olfactory Disfunction and Co-ultraPEALut

NCT05461365Phase 3Completed

Intranasal Insulin for COVID-19-related Smell Loss

NCT04710394Not ApplicableCompleted

Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell

Scroll to load more

Research Network

Activity Timeline